Dannielle Appelhans

CIK 1874962 · CEO and President · last filed 2026-02-09

Dannielle Appelhans is a CEO and President who has filed 12 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for GBIO, was dated Feb 9, 2026. Across all open-market trades the lifetime net is +$25.5K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

12

Lifetime Open-Market Net

$25.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Generation Bio Co. (GBIO) Delisted Director 0 $5.34 $0 $32.3K 7 2026-02-09
Rubius Therapeutics, Inc. (RUBY) Delisted CEO and President 0 $0.08 $0 -$6.9K 5 2023-02-27

Recent Filings

12 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-09 Generation Bio Co. (GBIO) Delisted Mixed −1,999 $0 EDGAR
2025-06-06 Generation Bio Co. (GBIO) Delisted Grant (A) $0 EDGAR
2024-06-10 Generation Bio Co. (GBIO) Delisted Grant (A) $0 EDGAR
2023-12-11 Generation Bio Co. (GBIO) Delisted Buy (P) +8,000 $14.3K EDGAR
2023-12-06 Generation Bio Co. (GBIO) Delisted Buy (P) +12,000 $18.0K EDGAR
2023-06-12 Generation Bio Co. (GBIO) Delisted Grant (A) $0 EDGAR
2023-02-27 Rubius Therapeutics, Inc. (RUBY) Delisted Sell (S) −10,385 -$1.3K EDGAR
2023-02-01 Rubius Therapeutics, Inc. (RUBY) Delisted Mixed +3,622 -$970 EDGAR
2022-08-12 Rubius Therapeutics, Inc. (RUBY) Delisted Mixed +6,763 -$4.6K EDGAR
2022-07-19 Generation Bio Co. (GBIO) Delisted Grant (A) $0 EDGAR
Showing 110 of 12
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.